Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants Publisher Pubmed



Sharifi E1 ; Yousefiasl S2 ; Trovato M3 ; Sartorius R3 ; Esmaeili Y4 ; Goodarzi H5, 6 ; Ghomi M7 ; Bigham A1 ; Moghaddam FD8 ; Heidarifard M5, 6 ; Pourmotabed S9 ; Nazarzadeh Zare E7 ; Paivasantos AC10, 11 ; Rabiee N12, 13 Show All Authors
Authors
  1. Sharifi E1
  2. Yousefiasl S2
  3. Trovato M3
  4. Sartorius R3
  5. Esmaeili Y4
  6. Goodarzi H5, 6
  7. Ghomi M7
  8. Bigham A1
  9. Moghaddam FD8
  10. Heidarifard M5, 6
  11. Pourmotabed S9
  12. Nazarzadeh Zare E7
  13. Paivasantos AC10, 11
  14. Rabiee N12, 13
  15. Wang X14
  16. Tay FR15
Show Affiliations
Authors Affiliations
  1. 1. Department of Tissue Engineering and Biomaterials, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, 6517838736, Iran
  2. 2. Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Naples, 80131, Italy
  4. 4. School of Advanced Technologies in Medicine, Biosensor Research Center, Isfahan University of Medical Sciences, Isfahan, 8174673461, Iran
  5. 5. Centre de recherche, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
  6. 6. Department d’Ophtalmologie, Universite de Montreal, Montreal, QC, Canada
  7. 7. School of Chemistry, Damghan University, Damghan, 36716-45667, Iran
  8. 8. Institute for Photonics and Nanotechnologies, National Research Council, Via Fosso del Cavaliere, 100, Rome, 00133, Italy
  9. 9. Department of Emergency Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, 6517838736, Iran
  10. 10. Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, 3000-548, Portugal
  11. 11. Group of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, 3000-548, Portugal
  12. 12. School of Engineering, Macquarie University, Sydney, 2109, NSW, Australia
  13. 13. Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu, Gyeongbuk, Pohang, 37673, South Korea
  14. 14. Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University Shanghai Medical College, Shanghai, 200032, China
  15. 15. The Graduate School, Augusta University, Augusta, 30912, GA, United States

Source: Journal of Nanobiotechnology Published:2023


Abstract

Viruses are a major cause of mortality and socio-economic downfall despite the plethora of biopharmaceuticals designed for their eradication. Conventional antiviral therapies are often ineffective. Live-attenuated vaccines can pose a safety risk due to the possibility of pathogen reversion, whereas inactivated viral vaccines and subunit vaccines do not generate robust and sustained immune responses. Recent studies have demonstrated the potential of strategies that combine nanotechnology concepts with the diagnosis, prevention, and treatment of viral infectious diseases. The present review provides a comprehensive introduction to the different strains of viruses involved in respiratory diseases and presents an overview of recent advances in the diagnosis and treatment of viral infections based on nanotechnology concepts and applications. Discussions in diagnostic/therapeutic nanotechnology-based approaches will be focused on H1N1 influenza, respiratory syncytial virus, human parainfluenza virus type 3 infections, as well as COVID-19 infections caused by the SARS-CoV-2 virus Delta variant and new emerging Omicron variant. Graphical Abstract: [Figure not available: see fulltext.] © 2023, The Author(s).
Related Docs
View other Related Docs
1. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
2. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery Against Viral Associated Respiratory Infectious Diseases (Varid), International Journal of Molecular Sciences (2021)
3. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)
4. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
5. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)
6. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
7. Current Advances and Challenges in Covid-19 Vaccine Development: From Conventional Vaccines to Next-Generation Vaccine Platforms, Molecular Biology Reports (2022)
8. The Quest for a Better Fight: How Can Nanomaterials Address the Current Therapeutic and Diagnostic Obstacles in the Fight Against Covid-19?, Journal of Drug Delivery Science and Technology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (36)
Fazel Shokri (5)
Other Related Docs
9. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
10. Nanobiocide Based-Silver Nanomaterials Upon Coronaviruses: Approaches for Preventing Viral Infections, Nanoscale Research Letters (2021)
11. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)
12. Immune-Epidemiological Parameters of the Novel Coronavirus–A Perspective, Expert Review of Clinical Immunology (2020)
13. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
14. Green Chemistry and Coronavirus, Sustainable Chemistry and Pharmacy (2021)
15. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
16. Epitope Mapping of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Receptor Binding Domain-Specific Monoclonal Antibodies, Frontiers in Medicine (2022)
17. Aunp-Based Biosensors for the Diagnosis of Pathogenic Human Coronaviruses: Covid-19 Pandemic Developments, Analytical and Bioanalytical Chemistry (2022)
18. Point-Of-Use Rapid Detection of Sars-Cov-2: Nanotechnology-Enabled Solutions for the Covid-19 Pandemic, International Journal of Molecular Sciences (2020)
19. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
20. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
21. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
22. Vlp-Based Covid-19 Vaccines: An Adaptable Technology Against the Threat of New Variants, Vaccines (2021)
23. A Comparison Between Sars-Cov-1 and Sars-Cov2: An Update on Current Covid-19 Vaccines, DARU# Journal of Pharmaceutical Sciences (2022)
24. Delving Into Revolutionary Sars-Cov-2 Vaccine Approaches: Molecular and Virological Examinations; Principles of Sars-Cov-2 Vaccine Platform; [Adentrandose En Enfoques Revolucionarios De Vacunas Sars-Cov-2: Examenes Moleculares Y Virologicos; Principios De La Plataforma De Vacunas Sars-Cov-2], Vacunas (2024)
25. Immunoediting in Sars-Cov-2: Mutual Relationship Between the Virus and the Host, International Immunopharmacology (2022)
26. An Overview on the Seven Pathogenic Human Coronaviruses, Reviews in Medical Virology (2022)
27. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
28. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
29. Covid-19: Significance of Antibodies, Human Antibodies (2020)
30. On the Bioactivity and Mechanical Properties of Gehlenite Nanobioceramic: A Comparative Study, Journal of Medical Signals and Sensors (2020)
31. Classification of Viral Proteins Expressed by the Sars-Cov-2 Genome, Acta Microbiologica Hellenica (2022)
32. Convalescent Plasma Against Covid-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases, Microorganisms (2020)
33. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
34. Immune Responses and Pathogenesis of Sars-Cov-2 During an Outbreak in Iran: Comparison With Sars and Mers, Reviews in Medical Virology (2020)
35. Recent Developments in Sars-Cov-2 Vaccines: A Systematic Review of the Current Studies, Reviews in Medical Virology (2023)
36. Synthesis and Characterization of Vitamin D3-Functionalized Carbon Dots for Crispr/Cas9 Delivery, Nanomedicine (2021)
37. State-Of-The-Art Cerium Nanoparticles As Promising Agents Against Human Viral Infections, Biomedicine and Pharmacotherapy (2022)
38. Structure-Based Study of Immune Receptors As Eligible Binding Targets of Coronavirus Sars-Cov-2 Spike Protein, Journal of Molecular Graphics and Modelling (2021)
39. The Trend of Crispr-Based Technologies in Covid-19 Disease: Beyond Genome Editing, Molecular Biotechnology (2023)
40. Evidence for Sars-Cov-2 Circulating Among Stray Dogs and Cats: Should We Worry About Our Pets During the Covid-19 Pandemic?, Biomedical and Biotechnology Research Journal (2020)
41. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
42. Covid-19 Vaccination Challenges: A Mini-Review, Human Vaccines and Immunotherapeutics (2022)
43. Cytokine Storm in the Pathophysiology of Covid-19: Possible Functional Disturbances of Mirnas, International Immunopharmacology (2021)
44. The Urgent Need for Integrated Science to Fight Covid-19 Pandemic and Beyond, Journal of Translational Medicine (2020)
45. Evaluation of Relationship Between Risk Factors of Cardiovascular Disease and Morbidity and Mortality of Covid-19 Patients, Journal of Iranian Medical Council (2023)
46. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
47. Dental Care Management During the Covid-19 Outbreak, Special Care in Dentistry (2020)
48. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)
49. Melatonin Could Be Beneficial in Sars-Cov-2 Therapy, Natural Products Journal (2021)
50. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)